Genprex Stock (NASDAQ:GNPX)
Previous Close
$0.22
52W Range
$0.20 - $3.97
50D Avg
$0.26
200D Avg
$0.58
Market Cap
$7.10M
Avg Vol (3M)
$2.01M
Beta
-0.52
Div Yield
-
GNPX Company Profile
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.